The only two things in common between Revive and Relief is the word drug and the FDA will be involved. The creator of Relief’s drug spent 30 years trying to find a clinical use and died before he found one!! It was never approved or used in any thing past a clinical trial! On top of that their trial was not laid out well and the CEO of Novavex Relief’s co-sponsor was a bloviating pumper and is now under investigation. Bucillamine has actually been used to treat diseases for over 30 years and has a fantastic well documented safety history. It has also been given an orphan drug status recently to treat ischemia in liver transplants by the FDA! The FDA will not take long with their decision for Revive concerning end points. Revive has a drug that is safe and utilizes different modes of action as a anti-inflammatory that no other approved Covid therapeutic uses. Not only has it shown in vitro as well as at the first 210 patient trial interim that it works it’s M.O.As bode well as a possible solution for long Covid. There is no comparison between Relief and Revive and the FDA will most certainly treat them differently!!
News 
Market Data 
Discover 
